PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
-
England's Rashford unfazed by high-altitude Mexico World Cup test
-
Iranians begin to gather for Khamenei funeral ceremonies
-
In Brazil, Bolsonaro family airs feud ahead of elections
-
England v Mexico World Cup kickoff could be moved earlier: source
-
Postecoglou links up with Ronaldo at Al Nassr
-
Frustrated families demand recovery of Venezuela's earthquake dead
-
Sabalenka sets up Wimbledon last-16 clash with Osaka
-
Williams sisters return, Swiatek faces Eala test at Wimbledon
-
Dangerous heatwave hits peak temps along US east coast
-
'Ecstatic' Hamilton rolls back the years with Silverstone pole
-
LeBron's agent makes case for 10 new clubs for 41-year-old star
-
England enter World Cup lion's den as Mexico host them at Azteca fortress
-
Trump heads for Mount Rushmore as US turns 250
-
Hamilton beats Antonelli to British GP sprint pole with supreme lap
-
French Top 14 champions Toulouse fined for salary cap breaches
-
Title rivals Djokovic and Sinner advance at Wimbledon
-
Record-equalling Djokovic powers into Wimbledon last 16
-
Ferrari confirm Hamilton staying next year
-
Ruthless Sinner powers into Wimbledon last 16
-
Global frenzy over Swift, Kelce's glittering 'royal wedding'
-
England's Kane feels 'as good as ever' ahead of Mexico World Cup clash
-
Three acquitted of 2019 murder of N.Irish journalist Lyra McKee
-
French Top 14 champions Toulouse fined for salary breaches
-
Stokes bids farewell to fans after 'mad 15 years'
-
Thousands more head for South Africa's borders
-
One for the history books: what we know about the European heatwave
-
Australia upbeat about 'ultimate professional' Perry's fitness for World Cup final
-
Dutch FA to sue over racist slurs after World Cup exit
-
Ukraine backers to vow major support at NATO summit
-
Mercedes demos set stage for wave of German auto protests
-
Ayuso happy to fly under radar at Tour de France
-
Iran leaders pay last respects to Khamenei as mourners gather
-
Curran ready to fill England gap left by Stokes exit
-
UN issues 'red alert' over 'catastrophe' in Sudan's El-Obeid
-
Djokovic has history on the line at Wimbledon
-
Tour de France to start with team time-trial 'bang'
-
Hamilton sparkles in Silverstone sunshine
-
Dressed for success: Osaka reaches Wimbledon last 16 for first time
-
Swift and Kelce set to tie the knot in glitzy arena extravaganza
-
Bayern sign Germany defender Brown until 2031
-
Police hunt for Ukrainian woman over Monaco bomb attack
-
MEXC's June Highlights: $437 Billion in Trading Volume, Offering Access to 7,000+ US Stocks and ETFs
-
Kenya's abortion taboo is killing thousands of women
-
Stocks mostly rise as beaten-down tech stocks enjoy bounce
-
Madonna returns to form with dancefloor filler "Confessions II"
-
Iranian leaders pay respects to supreme leader as Tehran prepares for funeral
-
Dean says Australia final a 'fresh start' for England
-
Doubles not a 'carnival sideshow' say players amid schedule row
-
Wimbledon giving Serena 'as much time' as possible for doubles
-
Klopp in 'talks' for Germany job after Nagelsmann exit: federation
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The Investor Summit Group (ISG), today announced that Ori Warshavsky, Chief Operating Officer - US Operations and Jonny Missulawin, Chief Financial Officer of PolyPid Ltd. (Nasdaq:PYPD), a late-stage biopharma company aiming to improve surgical outcomes will be presenting at this year's Investor Summit Virtual Conference on March 11th, 2025.
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid at the conference should contact their ISG representative.
About PolyPid Ltd.
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional PolyPid information, please visit http://www.polypid.com and follow on Twitter and LinkedIn.
Event: Q1 Investor Summit Virtual Conference
Presentation Time: 10:00 AM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52088
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
ACCESS Newswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESS Newswire
For More Information please visit: https://investorsummitgroup.com/
Or contact [email protected]
SOURCE: PolyPid Ltd.
View the original press release on ACCESS Newswire
P.Stevenson--AMWN
